Results 111 to 120 of about 276,341 (309)

Engineering Ultrasound Contrast Agents for Targeted Therapeutics: A Theranostic Approach to Drug Delivery, Gene Therapy, and Immunomodulation

Advanced NanoBiomed Research, EarlyView.
Ultrasound contrast agents, including microbubbles and nanobubbles, transform imaging and targeted therapy through precise engineering of size, shell composition, and surface properties. This review explores how these innovations enable tissue‐specific delivery, enhance therapeutic efficacy, and extend applications from vascular imaging to tumor ...
Ashkan Seza, Kimia Mozahheb Yousefi, Sara Minaeian   +2 more
wiley   +1 more source

Anti‐Osteoporosis Medications Associated with Decreased Mortality after Hip Fracture [PDF]

, 2019
Pei‐wen Wang, Yizhong Li, Huafeng Zhuang, Haiming Yu, Siqing Cai, Hao Xu, Zhen‐hui Chen, Jinkuang Lin, Xuedong Yao   +8 more
openalex   +1 more source

Cytokine pathways driving diverse tissue pathologies in rheumatoid arthritis

Arthritis &Rheumatology, Accepted Article.
Rheumatoid arthritis is a complex systemic disorder characterised primarily by articular inflammation and destruction with associated functional loss and reduced quality of life. RA is also associated with extra‐articular disease e.g. of the lung with potentially devastating clinical consequences.
Aurelie Najm, Lyn D. Ferguson, Iain B. McInnes   +2 more
wiley   +1 more source

The yield of routine laboratory examination in osteoporosis evaluation in primary care [PDF]

Thomas Merlijn, Karin M. A. Swart, Christy Niemeijer, Henriëtte E. van der Horst, Coen Netelenbos, Petra J. M. Elders   +5 more
openalex   +1 more source

OP0248 GENETIC EVIDENCE REVEALS THE CAUSAL RELATIONSHIP BETWEEN OSTEOPOROSIS AND CARDIOVASCULAR DISEASE [PDF]

, 2023
Yayu Bai, Xiaoyan Yin, Q. Y. Su, R. T. Shen, Feng Yang, Qi Yu, P. F. He, X. LI, S. X. Zhang   +8 more
openalex   +1 more source

The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With Polyangiitis

Arthritis &Rheumatology, EarlyView.
Objective The phase 3 MANDARA study demonstrated noninferiority of benralizumab versus mepolizumab for remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA). More benralizumab‐treated patients achieved complete withdrawal of oral glucocorticoids (OGCs).
Parameswaran K. Nair, Bernhard Hellmich, Arnaud Bourdin, David R. W. Jayne, Florence Roufosse, Nader Khalidi, Lena Börjesson Sjö, Ying Fan, Christopher McCrae, Sofia Necander, Eva Rodríguez‐Suárez, Anat Shavit, Claire Walton, Peter A. Merkel, Michael E. Wechsler   +14 more
wiley   +1 more source

4. Physiopathology and Prevention of Steroidal Osteoporosis.

, 2010
Ryouichi Takayanagi
openalex   +2 more sources

VA‐Based Survey of Osteoporosis Management in Spinal Cord Injury [PDF]

, 2009
Leslie R. Morse, Lora Giangregorio, Ricardo A. Battaglino, Robert Holland, B. Catharine Craven, Kelly Stolzmann, A Lazzari, Sunil Sabharwal, Eric Garshick   +8 more
openalex   +1 more source

Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis

Arthritis &Rheumatology, Accepted Article.
Background Transition from long‐term denosumab to PTH‐analogs or romosozumab might expose patients to the risk of the so‐called rebound phenomenon. Adding romosozumab to denosumab might represent an option in patients experiencing a fracture while on denosumab.
Giovanni Adami, Francesco Pollastri, Angelo Fassio, Filippo Montanari, Anna Piccinelli, Camilla Benini, Emma Pasetto, Carmen Dartizio, Davide Gatti, Maurizio Rossini, Ombretta Viapiana   +10 more
wiley   +1 more source

ASSESSMENT OF AWARENESS OF FAMILY PHYSICIANSABOUT THE OSTEOPOROSIS AS A PROBLEM OF ELDERLY

, 2017
Olga Yu. Kuznetsova, Irina Е. Moiseeva
openalex   +2 more sources